Abstract
High-throughput diagnostic assays are required for large-scale population testing for severe acute respiratory coronavirus 2 (SARS-CoV-2). The gold standard technique for SARS-CoV-2 detection in nasopharyngeal swab specimens is nucleic acid extraction followed by real-time reverse transcription-PCR. Two high-throughput commercial extraction and detection systems are used routinely in our laboratory: the Roche cobas SARS-CoV-2 assay (cobas) and the Roche MagNA Pure 96 system combined with the SpeeDx PlexPCR SARS-CoV-2 assay (Plex). As an alternative to more costly instrumentation, or tedious sample pooling to increase throughput, we developed a high-throughput extraction-free sample preparation method for naso-oropharyngeal swabs using the PlexPCR SARS-CoV-2 assay (Direct). A collection of SARS-CoV-2-positive ( n = 185) and -negative ( n = 354) naso-oropharyngeal swabs in transport medium were tested in parallel to compare Plex to Direct. The overall agreement comparing the qualitative outcomes was 99.3%. The mean cycle of quantification ( C q ) increase and corresponding mean reduction in viral load for Direct ORF1ab and RdRp compared to Plex was 3.11 C q (-0.91 log 10 IU/mL) and 4.78 C q (-1.35 log 10 IU/mL), respectively. We also compared Direct to a four-sample pool by combining each positive sample ( n = 185) with three SARS-CoV-2-negative samples extracted with MagNA Pure 96 and tested with the PlexPCR SARS-CoV-2 assay (Pool). Although less sensitive than Plex or Pool, the Direct method is a sufficiently sensitive and viable approach to increase our throughput by 12,032 results per day. Combining cobas, Plex, and Direct, an overall throughput of 19,364 results can be achieved in a 24-h period. IMPORTANCE Laboratories have experienced extraordinary demand globally for reagents, consumables, and instrumentation, while facing unprecedented testing demand needed for the diagnosis of SARS-CoV-2 infection. A major bottleneck in testing throughput is the purification of viral RNA. Extraction-based methods provide the greatest yield and purity of RNA for downstream PCR. However, these techniques are expensive, time-consuming, and depend on commercial availability of consumables. Extraction-free methods offer an accessible and cost-effective alternative for sample preparation. However, extraction-free methods often lack sensitivity compared to extraction-based methods. We describe a sensitive extraction-free protocol based on a simple purification step using a chelating resin, combined with proteinase K and thermal treatment. We compare the sensitivity qualitatively and quantitatively to a well-known commercial extraction-based system, using a PCR assay calibrated to the 1st WHO international standard for SARS-CoV-2 RNA. This method entails high throughput and is suitable for all laboratories, particularly in jurisdictions where access to instrumentation and reagents is problematic.
Keywords: PlexPCR; SARS-CoV-2; cobas; extraction-free; high-throughput.
【저자키워드】 SARS-CoV-2, extraction-free, Cobas, high-throughput., PlexPCR, 【초록키워드】 Treatment, protocol, Infection, diagnostic, outcome, reverse transcription-PCR, RNA, SARS-CoV-2 detection, sensitivity, PCR, Viral load, International, RdRP, WHO, SARS-CoV-2 RNA, Viral RNA, Roche, quantification, extraction-free method, ORF1ab, direct method, Transport, medium, gold standard, pool, reagents, nucleic acid extraction, PCR assay, proteinase, purification, reagent, offer, positive sample, downstream, nasopharyngeal swab specimen, Direct, approach, Respiratory Coronavirus, detection system, log, tested, lack, required, per day, less, costly, reduction in, time-consuming, calibrated, diagnosis of SARS-CoV-2, naso-oropharyngeal swab, 【제목키워드】 COVID-19, Testing, sensitive, preparation, Sample,